SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Michel Neidhart, DNA Methylation and Complex Human Disease, 2016,

    CrossRef

  2. 2
    Jianli Li, Hongzheng Dai, Yanming Feng, Jia Tang, Stella Chen, Xia Tian, Elizabeth Gorman, Eric S. Schmitt, Terah A.A. Hansen, Jing Wang, Sharon E. Plon, Victor Wei Zhang, Lee-Jun C. Wong, A Comprehensive Strategy for Accurate Mutation Detection of the Highly Homologous PMS2, The Journal of Molecular Diagnostics, 2015, 17, 5, 545

    CrossRef

  3. 3
    G. Cini, I. Carnevali, M. Quaia, A. M. Chiaravalli, P. Sala, E. Giacomini, R. Maestro, M. G. Tibiletti, A. Viel, Concomitant mutation and epimutation of the MLH1 gene in a Lynch syndrome family, Carcinogenesis, 2015, 36, 4, 452

    CrossRef

  4. 4
    M.P. Hitchins, H.T. Lynch, Dawning of the epigenetic era in hereditary cancer, Clinical Genetics, 2014, 85, 5
  5. 5
    Alexander M. Metcalf, Amanda B. Spurdle, Endometrial tumour BRAF mutations and MLH1 promoter methylation as predictors of germline mismatch repair gene mutation status: a literature review, Familial Cancer, 2014, 13, 1, 1

    CrossRef

  6. 6
    P. Peltomäki, Epigenetic mechanisms in the pathogenesis of Lynch syndrome, Clinical Genetics, 2014, 85, 5
  7. 7
    Jennifer Rhees, Mildred Arnold, C. Richard Boland, Inversion of exons 1–7 of the MSH2 gene is a frequent cause of unexplained Lynch syndrome in one local population, Familial Cancer, 2014, 13, 2, 219

    CrossRef

  8. 8
    Alexandra Thiel, Mira Heinonen, Jonas Kantonen, Annette Gylling, Laura Lahtinen, Mari Korhonen, Soili Kytölä, Jukka-Pekka Mecklin, Arto Orpana, Päivi Peltomäki, Ari Ristimäki, BRAF mutation in sporadic colorectal cancer and Lynch syndrome, Virchows Archiv, 2013, 463, 5, 613

    CrossRef

  9. 9
    Francesca Duraturo, Angela Cavallo, Raffaella Liccardo, Bianca Cudia, Marina De Rosa, Giuseppe Diana, Paola Izzo, Contribution of Large Genomic Rearrangements in Italian Lynch Syndrome Patients: Characterization of a Novel Alu-Mediated Deletion, BioMed Research International, 2013, 2013, 1

    CrossRef

  10. 10
    Robyn L. Ward, Timothy Dobbins, Noralane M. Lindor, Robert W. Rapkins, Megan P. Hitchins, Identification of constitutional MLH1 epimutations and promoter variants in colorectal cancer patients from the Colon Cancer Family Registry, Genetics in Medicine, 2013, 15, 1, 25

    CrossRef

  11. 11
    Cecily P. Vaughn, Christine L. Baker, Wade S. Samowitz, Jeffrey J. Swensen, The frequency of previously undetectable deletions involving 3′ Exons of the PMS2 gene, Genes, Chromosomes and Cancer, 2013, 52, 1
  12. 12
    Megan P. Hitchins, The role of epigenetics in Lynch syndrome, Familial Cancer, 2013, 12, 2, 189

    CrossRef

  13. 13
    T Pal, M R Akbari, P Sun, J-H Lee, J Fulp, Z Thompson, D Coppola, S Nicosia, T A Sellers, J McLaughlin, H A Risch, B Rosen, P Shaw, J Schildkraut, S A Narod, Frequency of mutations in mismatch repair genes in a population-based study of women with ovarian cancer, British Journal of Cancer, 2012, 107, 10, 1783

    CrossRef

  14. 14
    A O von Bueren, M D Bacolod, C Hagel, K Heinimann, A Fedier, U Kordes, T Pietsch, J Koster, M A Grotzer, H S Friedman, G Marra, M Kool, S Rutkowski, Mismatch repair deficiency: a temozolomide resistance factor in medulloblastoma cell lines that is uncommon in primary medulloblastoma tumours, British Journal of Cancer, 2012, 107, 8, 1399

    CrossRef

  15. 15
    Marta Pineda, Pilar Mur, María Dolores Iniesta, Ester Borràs, Olga Campos, Gardenia Vargas, Sílvia Iglesias, Anna Fernández, Stephen B Gruber, Conxi Lázaro, Joan Brunet, Matilde Navarro, Ignacio Blanco, Gabriel Capellá, MLH1 methylation screening is effective in identifying epimutation carriers, European Journal of Human Genetics, 2012, 20, 12, 1256

    CrossRef

  16. 16
    Päivi Peltomäki, Mutations and epimutations in the origin of cancer, Experimental Cell Research, 2012, 318, 4, 299

    CrossRef

  17. 17
    Ajay Goel, Thuy-Phuong Nguyen, Hon-Chiu E. Leung, Takeshi Nagasaka, Jennifer Rhees, Erin Hotchkiss, Mildred Arnold, Pia Banerji, Minoru Koi, Chau-To Kwok, Deborah Packham, Lara Lipton, C. Richard Boland, Robyn L. Ward, Megan P. Hitchins, De novo constitutional MLH1 epimutations confer early-onset colorectal cancer in two new sporadic Lynch syndrome cases, with derivation of the epimutation on the paternal allele in one, International Journal of Cancer, 2011, 128, 4
  18. 18
    Megan P. Hitchins, Robert W. Rapkins, Chau-To Kwok, Sameer Srivastava, Justin J.L. Wong, Levon M. Khachigian, Patsie Polly, Jack Goldblatt, Robyn L. Ward, Dominantly Inherited Constitutional Epigenetic Silencing of MLH1 in a Cancer-Affected Family Is Linked to a Single Nucleotide Variant within the 5′UTR, Cancer Cell, 2011, 20, 2, 200

    CrossRef

  19. 19
    Inês Francisco, Cristina Albuquerque, Pedro Lage, Hélio Belo, Inês Vitoriano, Bruno Filipe, Isabel Claro, Sara Ferreira, Paula Rodrigues, Paula Chaves, Carlos Nobre Leitão, António Dias Pereira, Familial colorectal cancer type X syndrome: two distinct molecular entities?, Familial Cancer, 2011, 10, 4, 623

    CrossRef

  20. 20
    MP Hitchins, SE Owens, C-T Kwok, G Godsmark, UF Algar, RS Ramesar, Identification of new cases of early-onset colorectal cancer with an MLH1 epimutation in an ethnically diverse South African cohort, Clinical Genetics, 2011, 80, 5
  21. 21
    Maria José Cabello, Laura Grau, Noreli Franco, Esteban Orenes, Miguel Alvarez, Ana Blanca, Oscar Heredero, Alberto Palacios, Manuel Urrutia, Jesus María Fernández, Antonio López-Beltrán, Marta Sánchez-Carbayo, Multiplexed Methylation Profiles of Tumor Suppressor Genes in Bladder Cancer, The Journal of Molecular Diagnostics, 2011, 13, 1, 29

    CrossRef

  22. 22
    Ajay Goel, Rosa M. Xicola, Thuy–Phuong Nguyen, Brian J. Doyle, Vanessa R. Sohn, Prathap Bandipalliam, Laura S. Rozek, Josep Reyes, Carmen Cordero, Francesc Balaguer, Antoni Castells, Rodrigo Jover, Montserrat Andreu, Sapna Syngal, C. Richard Boland, Xavier Llor, Aberrant DNA Methylation in Hereditary Nonpolyposis Colorectal Cancer Without Mismatch Repair Deficiency, Gastroenterology, 2010, 138, 5, 1854

    CrossRef

  23. 23
    Maria S Pino, Daniel C Chung, Application of molecular diagnostics for the detection of Lynch syndrome, Expert Review of Molecular Diagnostics, 2010, 10, 5, 651

    CrossRef

  24. 24
    Chau-To Kwok, Robyn L. Ward, Nicholas J. Hawkins, Megan P. Hitchins, Detection of allelic imbalance in MLH1 expression by pyrosequencing serves as a tool for the identification of germline defects in Lynch syndrome, Familial Cancer, 2010, 9, 3, 345

    CrossRef

  25. 25
    Eunjeong Jang, Daniel C. Chung, Hereditary Colon Cancer: Lynch Syndrome, Gut and Liver, 2010, 4, 2, 151

    CrossRef

  26. 26
    Lucía Pérez-Carbonell, Cristina Alenda, Artemio Payá, Adela Castillejo, Víctor M. Barberá, Carmen Guillén, Estefanía Rojas, Nuria Acame, Francisco J. Gutiérrez-Aviñó, Antoni Castells, Xavier Llor, Montserrat Andreu, José-Luis Soto, Rodrigo Jover, Methylation Analysis of MLH1 Improves the Selection of Patients for Genetic Testing in Lynch Syndrome, The Journal of Molecular Diagnostics, 2010, 12, 4, 498

    CrossRef

  27. 27
    Ajay Goel, Clement Richard Boland, Recent insights into the pathogenesis of colorectal cancer, Current Opinion in Gastroenterology, 2010, 26, 1, 47

    CrossRef

  28. 28
    Shih-Ching Chang, Pei-Ching Lin, Shung-Haur Yang, Huann-Sheng Wang, Wen-Yih Liang, Jen-Kou Lin, Taiwan hospital-based detection of Lynch syndrome distinguishes 2 types of microsatellite instabilities in colorectal cancers, Surgery, 2010, 147, 5, 720

    CrossRef

  29. 29
    Megan P. Hitchins, Epigenetics and Cancer, Part A, 2010,

    CrossRef

  30. 30
    Mathew Aidan Sloane, Luke Benjamin Hesson, Robyn Lynne Ward, Epimutations and Cancer Susceptibility, eLS,